ALLERGAN RECEIVES PAN EUROPEAN LICENSE FOR GANFORT

Allergan, Inc. today announced that it has received the license from the European Commission to market Ganfort, Allergan's Lumigan/timolol combination product (bimatoprost/timolol ophthalmic solution) for the treatment of glaucoma, in the European Union.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20060525005229&newsLang=en)